Before the Race Even Starts: Early Intervention to Prevent Long-Term Late Effects From Childhood Cancer Therapies.

Authors

Etan Orgel, Karen C Burns, Joshua Gorlick, Lisa S Kahalley

Published in

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. Volume 46. Issue 3. Pages e517242. Epub Jun 18, 2026.

Abstract

Increasing treatment intensity has improved survival rates for children with cancer, resulting in an increasing population burdened with late effects from treatment. The Children's Oncology Group Survivorship Guidelines provide a compendium of late effects with recommendations for risk-adapted surveillance based on treatment components and intensity. However, many late effects from therapy are permanent; alternative strategies are therefore necessary to prevent their debilitating impact on the quality of life for childhood cancer survivors. Prevention of late effects via early intervention is an increasingly vital component of pediatric cancer therapy. In this review, we highlight three common and debilitating late effects amenable to this strategy: oncofertility and fertility preservation, cisplatin-induced ototoxicity (hearing loss) and otoprotection, and radiation-induced neurocognitive deficits and cognitive-sparing approaches. For each toxicity, current practice, knowledge gaps, and future directions are discussed.

PMID:
42314084
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.